The who risk factor index, risk of vertebral fractures and reduction in fracture risk with alendronate: The fracture invervention trial

被引：0
|
作者：
Cummings, S. R.
Palermo, L.
Ensrud, K. E.
Schousboe, J. T.
Johansson, H.
Kanis, J. A.
机构：
[1] Univ Calif San Francisco, San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Minnesota, Minneapolis, MN 55455 USA
[4] Parc Nicollet Hlth Serv, Minneapolis, MN USA
[5] WHO Collaborating Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [31] Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial
    R. D. Chapurlat
    L. Palermo
    P. Ramsay
    S. R. Cummings
    [J]. Osteoporosis International, 2005, 16 : 842 - 848
  • [32] Prevalent vertebral fracture and the risk of incident vertebral fracture - Reply
    Cauley, Jane A.
    Lui, Li-Yung
    Hillier, Teresa A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (14): : 1666 - 1667
  • [33] Strontium ranelate: vertebral and non-vertebral fracture risk reduction
    Seeman, Ego
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 : S17 - S20
  • [34] Effects of raloxifene or alendronate on fracture risk reduction:: Results from the EVA (Evista®/alendronate comparison) trial.
    Recker, R
    Kendler, D
    Recknor, C
    Rooney, T
    Lewiecki, EM
    Utian, WH
    Cauley, J
    Lorraine, J
    Qu, Y
    Kulkarni, PM
    Plouffe, L
    Stock, JL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S97 - S97
  • [35] The efficacy of alendronate, risedronte and etidronate in treatment of osteoporosis and in reducing the risk for vertebral fractures of rheumatoid arthritis patients(fracture intervention trial.)
    Nakayama, H
    Hagiwara, F
    Tohma, S
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S498 - S498
  • [36] VERTEBRAL FRACTURE RISK: ALENDRONATE TREATMENT ENHANCES ANTERIOR MICROSTRUCTURE IN OSTEOPOROTIC VERTEBRAE
    vom Scheidt, A.
    Krause, M.
    Puschel, K.
    Amling, M.
    Busse, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S456 - S456
  • [37] Predicting vertebral fractures: Small vertebral deformities increase the risk of subsequent vertebral fracture at one year - Fast and effective risk reduction with risedronate.
    Felsenberg, D.
    Recknor, C.
    Zhou, X.
    Grauer, A.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S208 - S209
  • [38] Risk factors for subsequent vertebral fracture after acute osteoporotic vertebral fractures
    Hiroyuki Inose
    Tsuyoshi Kato
    Shoichi Ichimura
    Hiroaki Nakamura
    Masatoshi Hoshino
    Daisuke Togawa
    Toru Hirano
    Yasuaki Tokuhashi
    Tetsuro Ohba
    Hirotaka Haro
    Takashi Tsuji
    Kimiaki Sato
    Yutaka Sasao
    Masahiko Takahata
    Koji Otani
    Suketaka Momoshima
    Kunihiko Takahashi
    Masato Yuasa
    Takashi Hirai
    Toshitaka Yoshii
    Atsushi Okawa
    [J]. European Spine Journal, 2021, 30 : 2698 - 2707
  • [39] Risk factors for subsequent vertebral fracture after acute osteoporotic vertebral fractures
    Inose, Hiroyuki
    Kato, Tsuyoshi
    Ichimura, Shoichi
    Nakamura, Hiroaki
    Hoshino, Masatoshi
    Togawa, Daisuke
    Hirano, Toru
    Tokuhashi, Yasuaki
    Ohba, Tetsuro
    Haro, Hirotaka
    Tsuji, Takashi
    Sato, Kimiaki
    Sasao, Yutaka
    Takahata, Masahiko
    Otani, Koji
    Momoshima, Suketaka
    Takahashi, Kunihiko
    Yuasa, Masato
    Hirai, Takashi
    Yoshii, Toshitaka
    Okawa, Atsushi
    [J]. EUROPEAN SPINE JOURNAL, 2021, 30 (09) : 2698 - 2707
  • [40] The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population
    Naves, M
    Díaz-López, JB
    Gómez, C
    Rodríguez-Rebollar, A
    Rodríguez-García, M
    Cannata-Andía, JB
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 (06) : 520 - 524
12345